Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07458542 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia

Name: Effectiveness and Safety of ONUREG (Oral Azacitidine) in Chinese Patients With Acute Myeloid Leukemia — clinical trial record (NCT07458542)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusCompleted

PhaseNot specified

SponsorBristol-Myers Squibb

Started2025-12-09

View on ClinicalTrials.gov ↗

Amendment history

2026-10-02

Trial completed

Study completion confirmed: February 2026 (last estimated March 2026)

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

Leukemia

2,553 trials monitored

See 134 trials at risk

Acute Myeloid Leukemia (AML)

1,196 trials monitored

See 63 trials at risk

The purpose of this study is to assess real-world effectiveness and safety of oral azacitidine in adults diagnosed with acute myeloid leukemia (AML) in Hong Kong

Trial Details

NCT Number	NCT07458542
Lead Sponsor	Bristol-Myers Squibb
Conditions	Acute Myeloid Leukemia (AML)
Enrollment	44 participants
Start Date	2025-12-09
Primary Completion	2026-01-09 (estimated)
Study Completion	2026-02-28 (estimated)
Updated on ClinicalTrials.gov	2026-10-01